Former Genentech leaders’ protein degrader startup nets $107M

Written By Christine Mackenzie

https://endpoints.news/former-genentech-leaders-protein-degrader-startup-epibiologics-nets-107m/

Christine Mackenzie
Previous

Google, Johnson & Johnson back protein degrader start-up
Next

EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology